Literature DB >> 18260761

Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.

Yoshinori Ito1, Yukiko Shibata-Watanabe, Yoko Ushijima, Jun-Ichi Kawada, Yukihiro Nishiyama, Seiji Kojima, Hiroshi Kimura.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) is characterized by recurrent infectious mononucleosis-like symptoms and has high mortality and morbidity. To clarify the mechanisms of CAEBV, the gene-expression profiles of peripheral blood obtained from patients with CAEBV were investigated. Twenty genes were differentially expressed in 4 patients with CAEBV. This microarray result was verified using a real-time reverse-transcriptase polymerase chain reaction assay in a larger group of patients with CAEBV. Eventually, 3 genes were found to be significantly upregulated: guanylate binding protein 1, tumor necrosis factor-induced protein 6, and guanylate binding protein 5. These genes may be associated with the inflammatory reaction or with cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18260761     DOI: 10.1086/527330

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Optimal treatment for chronic active Epstein-Barr virus disease.

Authors:  Jeffrey I Cohen
Journal:  Pediatr Transplant       Date:  2009-06

2.  Identification of a putative quantitative trait nucleotide in guanylate binding protein 5 for host response to PRRS virus infection.

Authors:  James E Koltes; Eric Fritz-Waters; Chris J Eisley; Igseo Choi; Hua Bao; Arun Kommadath; Nick V L Serão; Nicholas J Boddicker; Sam M Abrams; Martine Schroyen; Hyelee Loyd; Chris K Tuggle; Graham S Plastow; Leluo Guan; Paul Stothard; Joan K Lunney; Peng Liu; Susan Carpenter; Robert R R Rowland; Jack C M Dekkers; James M Reecy
Journal:  BMC Genomics       Date:  2015-05-28       Impact factor: 3.969

3.  Guanylate-binding protein 5 is a marker of interferon-γ-induced classically activated macrophages.

Authors:  Yukio Fujiwara; Yoshiyuki Hizukuri; Kyoko Yamashiro; Naoyuki Makita; Koji Ohnishi; Motohiro Takeya; Yoshihiro Komohara; Yasuhiro Hayashi
Journal:  Clin Transl Immunology       Date:  2016-11-02

4.  Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein-Barr virus infection.

Authors:  Huaqing Zhong; Xinran Hu; Andrew B Janowski; Gregory A Storch; Liyun Su; Lingfeng Cao; Jinsheng Yu; Jin Xu
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

5.  Identification of differential proteomics in Epstein-Barr virus-associated gastric cancer and related functional analysis.

Authors:  Zeyang Wang; Zhi Lv; Qian Xu; Liping Sun; Yuan Yuan
Journal:  Cancer Cell Int       Date:  2021-07-12       Impact factor: 5.722

Review 6.  Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.

Authors:  Sanjay de Mel; Joshua Zhi-Chien Tan; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  Front Pediatr       Date:  2019-01-17       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.